Mechanistic description
Loss of nuclear TDP-43 in ALS motor neurons first manifests as aberrant inclusion of the STMN2 cryptic exon 2a, producing a truncated non-functional STMN2 protein that impairs microtubule repair at the axon. This splicing defect precedes detectable cytoplasmic TDP-43 aggregation by at least 48h in iPSC motor neurons subjected to TDP-43 depletion, establishing STMN2 cryptic exon inclusion as the earliest measurable loss-of-function event. Restoring STMN2 function with antisense oligonucleotides should delay axonal degeneration even when cytoplasmic aggregates have already formed.
Evidence for (5)
[Amyotrophic lateral sclerosis (ALS) - diagnosis, course of disease and treatment options].
ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair.
The genetics of amyotrophic lateral sclerosis.
Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies.
TDP-43 Pathology in Alzheimer's Disease.